Theravance Biopharma Inc (TBPH)
Operating Income Growth
77.83%
Quarterly · Period ending:
TBPH Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported77.83%period ending
Latest reported77.83%period ending
TBPH Quarterly Operating Income YoY % (-26.03% → 77.83%)
Year-over-year change
High-resolution chart · PNG
TBPH operating income growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Income Growth |
|---|---|
| 77.8349% | |
| 59.4707% | |
| 290.9239% | |
| 40.4355% | |
| 82.6488% | |
| -28.7945% | |
| -47.4359% | |
| -23.71% | |
| 2.5926% | |
| 55.0136% | |
| 64.2017% | |
| 38.3185% | |
| 30.2065% | |
| 33.0736% | |
| 68.9658% | |
| 73.5111% | |
| 63.9666% | |
| 55.6299% | |
| 26.5695% | |
| 30.0202% | |
| 11.1755% | |
| -15.7514% | |
| -8.3858% | |
| -17.5059% | |
| -69.9218% | |
| 1.6154% | |
| -12.697% | |
| -4.4051% | |
| 12.7875% | |
| -13.3742% | |
| 20.9091% | |
| -9.5672% | |
| 25.21% | |
| -10.4489% | |
| -36.9022% | |
| -70.1708% | |
| -37.1055% | |
| -41.2732% | |
| -3.6935% | |
| 22.2787% | |
| -4.8661% | |
| -10.3479% | |
| 15.1765% | |
| 13.9167% | |
| 20.1266% | |
| 37.1239% | |
| -49.1674% | |
| -21.8706% | |
| -45.5792% | |
| -86.5419% | |
| -51.052% | |
| -26.0255% |